Research shows sotagliflozin is the first medication of its kind to significantly reduce both heart attacks and strokes
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with ...
Medpage Today on MSN10h
SGLT1/2 Inhibitor Cut Stroke, Heart Attack Risk in Diabetic Kidney Disease
The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...
News Medical on MSN6h
Sotagliflozin could be used to reduce the risk of deadly cardiovascular events, trial shows
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...
DC News Now on MSN14h
What’s Going Around: Love can be good for your heart
While proposing on Valentine’s Day can be very romantic, getting married can also be good for your heart because married men ...
WTAJ Altoona on MSN11h
What to know about weight loss drugs to keep your heart healthy
Losing weight can support better heart health, but now doctors are warning of their possible impacts on your heart. Ozempic, ...
News Medical on MSN19h
A step toward precision medicine: New drug targets for heart failure
A groundbreaking study in Nature Cardiovascular Research uncovers promising drug targets for heart failure (HF) and its ...
Johns Hopkins Medicine22h
Heart and Vascular Institute
Procedures are performed at Suburban Hospital. Celebrate American Heart Month with our expert advice on heart wellness and prevention. Learn about healthy recipes, heart risks and heart health tips ...